Please login to the form below

Not currently logged in
Email:
Password:

Non-24

This page shows the latest Non-24 news and features for those working in and with pharma, biotech and healthcare.

Generic Copaxone launches in US

Generic Copaxone launches in US

In a statement, Novartis said that Sandoz will offer "financial assistance to qualified patients, personalised injection training and 24-hour access to nurses for non-clinical questions" as part of the

Latest news

  • BMS' Opdivo backed as melanoma therapy in EU BMS' Opdivo backed as melanoma therapy in EU

    FDA approval as a second-line non-small cell lung cancer (NSCLC) therapy - a much larger market opportunity - in March. ... Vanda Pharmaceuticals got the go-ahead for Hetlioz (tasimelteon) for the treatment of non-24-hour sleep wake disorder in totally

  • Running medical meetings Running medical meetings

    The sensitivities of the 'world' sector manifest in secretive meetings, 24-hour emails, decisions and non-decisions, last minute changes and demands, security focus, approvals… and the list goes on.

  • FDA approves sleep disorder drug for blind people FDA approves sleep disorder drug for blind people

    Vanda Pharmaceuticals is now allowed to market its drug Hetlioz (tasimelteon) to treat a condition called non-24-hour sleep-wake disorder, which causes problems in the sleep cycle of blind ... Non-24 affects people who are completely blind as light does

  • FDA panel backs sleep pattern drug for blind FDA panel backs sleep pattern drug for blind

    A Food Drug and Administration (FDA) advisory committee voted unanimously to recommend approval of Vanda Pharmaceuticals' Hetlioz (tasimelteon) for non-24-hour disorder (N24) in the totally blind. ... As a result, they can "fully enjoy the opportunities

  • FDA sets new date for Eliquis review in atrial fibrillation

    The filing draws on data from the ARISTOTLE and AVERROES studies, which together enrolled 24, 000 patients with non-valvular AF and found that the new drug was more effective than ... Other anticoagulants currently available in the US for the prevention

More from news
Approximately 1 fully matching, plus 12 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Accession

Accession was a born from a passion and a vision. A passion to harness the power of market access to...

Latest intelligence

image 1
Redefining communications excellence
How to be heard in today’s multichannel, multistakeholder, multimedia world...
AZ Campus
AstraZeneca: building a new ‘open innovation’ pharma company
The construction of its new HQ has suffered some serious delays, but new R&D and commercial success are lifting AstraZeneca’s prospects...
Erik Nordkamp
In conversation with Pfizer’s Erik Nordkamp
Pfizer’s UK general manager talks to PME about the NHS at 70, the potential of pharma partnerships and some lessons from Europe...

Infographics